Mechanotransduction pathways in bone pathobiology.

Bone tissue undergoes continuous remodeling to maintain structural integrity and function. This process involves coordinated activity among osteocytes, osteoblasts, osteoclasts, and chondrocytes. These cells detect and respond to mechanical stimuli, initiating mechanotransduction pathways that regulate bone metabolism. Prior research has shown that mechanotransduction is central to maintaining skeletal homeostasis. However, gaps remain in understanding how specific signaling pathways contribute to disease progression. Recent studies have identified several mechano-responsive pathways, but their roles in bone disease remain partially unclear. No prior work had resolved the full extent of these pathways' involvement in disease onset. This uncertainty has driven recent investigations into molecular mechanisms underlying bone pathobiology. Understanding these pathways could improve diagnostic and therapeutic strategies.

This review aims to identify mechanotransduction pathways that respond to mechanical signals and contribute to bone disease. The authors focus on recent findings from the past five years to clarify which signaling molecules are mechano-responsive. The study seeks to bridge the gap between mechanotransduction and disease progression in bone and cartilage tissues. By analyzing current literature, the authors aim to highlight pathways that are most relevant to disease development. They also assess the potential of these pathways as biomarkers or therapeutic targets. The review does not propose new hypotheses but synthesizes existing evidence. The goal is to provide a comprehensive overview of mechano-responsive pathways in bone disease. This synthesis may guide future research directions in skeletal pathobiology.

The authors conducted a systematic review of recent literature published in the last five years. They focused on studies investigating mechanotransduction pathways in bone and cartilage. The review included analysis of signaling molecules and cascades linked to bone disease. The authors synthesized findings from multiple disciplines, including cell biology and biomechanics. They evaluated the role of genetic, hormonal, and biomechanical factors in pathway alterations. The review approach involved categorizing pathways based on their mechano-responsiveness. The authors also examined how these pathways serve as diagnostic or prognostic markers. Their synthesis emphasizes pathways that have been directly linked to disease progression.

The review identified several mechano-responsive signaling pathways involved in bone disease. These include pathways such as Wnt/β-catenin, YAP/TAZ, and integrin-mediated signaling. The Wnt/β-catenin pathway was found to regulate osteoblast differentiation in response to mechanical stress. YAP/TAZ signaling was shown to influence osteocyte mechanosensitivity and bone remodeling. Integrin signaling was linked to mechanotransduction in chondrocytes and osteoblasts. The authors reported that disruptions in these pathways correlate with osteoporosis and osteoarthritis. Specific molecules like sclerostin and RANKL were highlighted as potential biomarkers. The review also noted that few pathways have been targeted in therapeutic development. These findings suggest that mechanotransduction pathways could serve as diagnostic tools.

The authors synthesize evidence that specific mechanotransduction pathways are mechano-responsive and contribute to bone disease. They emphasize that Wnt/β-catenin, YAP/TAZ, and integrin signaling are most frequently implicated in disease progression. The review highlights that these pathways serve as potential biomarkers for early diagnosis. The authors also note that few of these pathways have been explored for therapeutic development. Their findings suggest that targeting these pathways could improve disease management. The review does not propose new pathways but consolidates existing evidence. The authors conclude that further research is needed to validate these pathways in clinical settings. Their synthesis provides a foundation for future studies on mechanotransduction in bone pathobiology.